Molina Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Molina Healthcare (MOH).

Price Target Range — 11 Quarters

Analyst Consensus — 14 Analysts

2Buy

11Hold

1Sell

Consensus RatingNeutral# Analysts14Avg. Consensus PT$244Upside to Avg. PT+19.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 27, 2026	JP Morgan	John Stansel	PT Raise	Neutral	$220→$225
Oct 23, 2026	UBS	A.J. Rice	PT Raise	Neutral	$202→$225
Oct 23, 2026	Morgan Stanley	Erin Wright	PT Raise	Equal-Weight	$167→$192
Oct 23, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$218→$222
Oct 23, 2026	Barclays	Andrew Mok	PT Cut	Underweight	$180→$178
Jul 28, 2026	Wells Fargo	Stephen Baxter	PT Cut	Equal-Weight	$235→$220
Jul 24, 2026	Truist Securities	David Macdonald	PT Cut	Hold	$250→$225
Jul 24, 2026	RBC Capital	Ben Hendrix	PT Cut	Sector Perform	$248→$218
Jul 24, 2026	Barclays	Andrew Mok	PT Cut	Underweight	$184→$180
Jul 14, 2026	TD Cowen	Ryan Langston	PT Raise	Hold	$163→$230
Jul 14, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$205→$250
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Raise	Equal-Weight	$159→$235
Jul 9, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$216→$248
Jul 9, 2026	Barclays	Andrew Mok	PT Cut	Underweight	$199→$184
Jun 23, 2026	RBC Capital	Ben Hendrix	Initiate	Sector Perform	$216
Jun 8, 2026	JP Morgan	John Stansel	PT Raise	Neutral	$169→$191
Jun 4, 2026	Morgan Stanley	Erin Wright	PT Raise	Equal-Weight	$146→$167
May 26, 2026	Barclays	Andrew Mok	PT Raise	Underweight	$161→$199
May 22, 2026	UBS	A.J. Rice	PT Raise	Neutral	$180→$202
May 11, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$180→$205

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Molina Healthcare, Raises Price Target to $225

JP Morgan analyst John Stansel maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $220 to $225.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $225

UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $202 to $225.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Molina Healthcare, Raises Price Target to $192

Morgan Stanley analyst Erin Wright maintains Molina Healthcare (NYSE:MOH) with a Equal-Weight and raises the price target from $167 to $192.

Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Molina Healthcare, Raises Price Target to $222

RBC Capital analyst Ben Hendrix maintains Molina Healthcare (NYSE:MOH) with a Sector Perform and raises the price target from $218 to $222.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178

Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $180 to $178.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $220

Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Equal-Weight and lowers the price target from $235 to $220.

Benzinga Newsdesk

Molina Healthcare Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Molina Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Molina Healthcare, Raises Price Target to $225

PRO
UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $225

PRO
Morgan Stanley Maintains Equal-Weight on Molina Healthcare, Raises Price Target to $192

PRO
RBC Capital Maintains Sector Perform on Molina Healthcare, Raises Price Target to $222

PRO
Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178

PRO
Wells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $220

People Also Watch

People Also Watch

Molina Healthcare Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Molina Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Neutral on Molina Healthcare, Raises Price Target to $225

PROUBS Maintains Neutral on Molina Healthcare, Raises Price Target to $225

PROMorgan Stanley Maintains Equal-Weight on Molina Healthcare, Raises Price Target to $192

PRORBC Capital Maintains Sector Perform on Molina Healthcare, Raises Price Target to $222

PROBarclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178

PROWells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $220

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Neutral on Molina Healthcare, Raises Price Target to $225

PRO
UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $225

PRO
Morgan Stanley Maintains Equal-Weight on Molina Healthcare, Raises Price Target to $192

PRO
RBC Capital Maintains Sector Perform on Molina Healthcare, Raises Price Target to $222

PRO
Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178

PRO
Wells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $220